David Bredt, Chief Scientific Officer: Rapport Therapeutics RAPP Planned sale · Filed 25/06/16

Trade details

Type: Planned sale notice
Stock: Rapport Therapeutics RAPP
Person: David BredtChief Scientific Officer
Planned sale date: 25/06/16
Filed: 25/06/16

More to sell after $162.6K in 3 months

Rapport Therapeutics trades, last 26 weeks

What else happened in Rapport Therapeutics around then

Filed or reported within 30 days of the trade day · 25/05/17~25/07/16

David Bredt's recent trades

David BredtChief Scientific Officer
Sell10b5-1 planRapport Therapeutics
Sell10b5-1 plan
Rapport Therapeutics
RAPP
$156.3K
5,400 sh
$156.3K
Filed 02/19
Traded 02/17
David BredtChief Scientific Officer
Sell10b5-1 planRapport Therapeutics
Sell10b5-1 plan
Rapport Therapeutics
RAPP
$65.1K
2,200 sh
$65.1K
Filed 02/19
Traded 02/17
David BredtChief Scientific Officer
Sell10b5-1 planRapport Therapeutics
Sell10b5-1 plan
Rapport Therapeutics
RAPP
$25.2K
900 sh
$25.2K
Filed 02/19
Traded 02/17
David BredtChief Scientific Officer
Sell10b5-1 planRapport Therapeutics
Sell10b5-1 plan
Rapport Therapeutics
RAPP
$222.7K
8,300 sh
$222.7K
Filed 01/16
Traded 01/15
David BredtChief Scientific Officer
Sell10b5-1 planRapport Therapeutics
Sell10b5-1 plan
Rapport Therapeutics
RAPP
$5,480
200 sh
$5,480
Filed 01/16
Traded 01/15

David Bredt, Chief Officer — plans to sell 34,000 sh of Rapport Therapeutics RAPP · $380.5K · around 06/16 · 10b5-1 plan | Whalegun